GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (NAS:BDSI) » Definitions » Days Payable

BioDelivery Sciences International (BioDelivery Sciences International) Days Payable : 100.11 (As of Dec. 2021)


View and export this data going back to 2002. Start your Free Trial

What is BioDelivery Sciences International Days Payable?

BioDelivery Sciences International's average Accounts Payable for the three months ended in Dec. 2021 was $7.6 Mil. BioDelivery Sciences International's Cost of Goods Sold for the three months ended in Dec. 2021 was $6.9 Mil. Hence, BioDelivery Sciences International's Days Payable for the three months ended in Dec. 2021 was 100.11.

The historical rank and industry rank for BioDelivery Sciences International's Days Payable or its related term are showing as below:

BDSI' s Days Payable Range Over the Past 10 Years
Min: 89.77   Med: 202.5   Max: 1275.75
Current: 89.77

During the past 13 years, BioDelivery Sciences International's highest Days Payable was 1275.75. The lowest was 89.77. And the median was 202.50.

BDSI's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 86.23 vs BDSI: 89.77

BioDelivery Sciences International's Days Payable increased from Dec. 2020 (68.53) to Dec. 2021 (100.11). It may suggest that BioDelivery Sciences International delayed paying its suppliers.

BioDelivery Sciences International Days Payable Historical Data

The historical data trend for BioDelivery Sciences International's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Days Payable Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 202.50 178.09 125.70 117.77 96.25

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.53 74.63 99.91 79.61 100.11

Competitive Comparison of BioDelivery Sciences International's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioDelivery Sciences International's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Days Payable distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's Days Payable falls into.


BioDelivery Sciences International Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

BioDelivery Sciences International's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

Days Payable (A: Dec. 2021 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2020 ) + Accounts Payable (A: Dec. 2021 )) / count ) / Cost of Goods Sold (A: Dec. 2021 )*Days in Period
=( (4.213 + 8.114) / 2 ) / 23.373*365
=6.1635 / 23.373*365
=96.25

BioDelivery Sciences International's Days Payable for the quarter that ended in Dec. 2021 is calculated as:

Days Payable (Q: Dec. 2021 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2021 ) + Accounts Payable (Q: Dec. 2021 )) / count ) / Cost of Goods Sold (Q: Dec. 2021 )*Days in Period
=( (7.033 + 8.114) / 2 ) / 6.903*365 / 4
=7.5735 / 6.903*365 / 4
=100.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioDelivery Sciences International Days Payable Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BioDelivery Sciences International (BioDelivery Sciences International) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (NAS:BDSI) » Definitions » Days Payable
Comparable Companies
SIGA VYGR BYSI PRTA ANIK RUBY DVAX BCEL IMRA XENE OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY
Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
Website
http://www.bdsi.com
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.
Executives
James Vollins officer: See Remarks C/O BIODELIVERY SCIENCES INTERNATIONAL, 4131 PARK LAKE AVE SUITE 225, RALEIGH NC 27607
Mark A Sirgo director C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE -SUITE 210, RALEIGH NC 27607
Broadfin Healthcare Master Fund Ltd director C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Kevin Kotler director C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Mary Theresa Coelho officer: See Remarks 52 SUNRISE PARK ROAD, NEW HAMPTON NY 43017
Jeffrey Allen Bailey director, officer: Chief Executive Officer BIODELIVERY SCIENCES INTERNATIONAL, INC., 4131 PARKLAKE AVE., SUITE 225, RALEIGH NC 27612
Todd C Davis director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
W. Mark Watson director 324 S. HYDE PARK AVENUE, STE 350, TAMPA FL 33606
Peter Greenleaf director ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878
Broadfin Capital, Llc director 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Vanila Singh director C/O BIODELIVERY SCIENCES INTERNATIONAL, 4131 PARKLAKE AVE., SUITE 225, RALEIGH NC 27612
Scott M. Plesha officer: See Remarks 1410 SMYTHE ST DANIEL ISLAND SC 29492
Odonnell Francis E Jr director BIODELIVERY SCIENCES INTERNATIONAL, INC, 4131 PARKLAKE AVENUE, SUITE #225, RALEIGH NC 27612
Herm Cukier director, officer: Chief Executive Officer C/O BIODELIVERY SCIENTES INT., INC. 4131 PARKLAKE AVE, SUITE 225 RALEIGH NC 27612
Thomas B Smith officer: Chief Medical Officer BIODELIVERY SCIENCES INTERNATIONAL, INC., 4131 PARKLAKE AVE SUITE 225, RALEIGH NC 27612